Human epidermal growth factor receptor 2 (HER-2), overexpressed in breast cancer, promotes tumor cell proliferation and invasion by activating the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian rapamycin target (mTOR) pathway [2]. Here, MTOR is linked to neoplasm.